Plenteous Pharmaceuticals Limited - Charges

Every charge - open or closed - that lenders have registered against Plenteous Pharmaceuticals Limited, with the most recent activity at the…

2008-12-11 Delhi, Delhi Active Unlisted Active Compliant
Share
Connect MCP
PP Plenteous Pharmaceuticals Limited
Open charges
1
5.00 cr
Closed charges
2
42.00 cr
Total
3
47.00 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Jp Morgan Chase Bank, N.A. 1 40.00 cr
2 Hdfc Bank Limited 1 5.00 cr
3 Icici Bank Limited 1 2.00 cr
All charges (3) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
100687919 Jp Morgan Chase Bank, N.A. 10 Mar 2023 - 24 Apr 2025 40.00 cr Closed
100273798 Hdfc Bank Limited 29 Jun 2019 - - 5.00 cr Open
10324921 Icici Bank Limited 12 Dec 2011 - 25 Mar 2019 2.00 cr Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Plenteous Pharmaceuticals Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Plenteous Pharmaceuticals Limited (CIN: U24232DL2008PLC185686). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Plenteous Pharmaceuticals Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.